CTNM EV/EBITDA

EV/EBITDA

-5.48
+0.28+4.86%

12 min ago


Summary


Performance

CTNM EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCTNMvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CTNM EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+4.9%-4.8%-4.0%
1 m1 month+39.7%-39.7%-35.3%
3 m3 months+55.7%-55.7%-51.0%
6 m6 months+51.6%-45.7%-46.1%
ytdytd+42.5%-42.5%-38.0%
1 y1 year---
5 y5 years---

CTNM EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high-9.42+41.8%
3 m3-month-5.48at high-13.16+58.4%
6 m6-month-5.48at high-13.95+60.7%
1 y1-year27.66-119.8%-15.32+64.2%
3 y3-year27.66-119.8%-15.32+64.2%
5 y5-year27.66-119.8%-15.32+64.2%
alltimeall time27.66-119.8%-15.32+64.2%

Contineum Therapeutics Class A EV/EBITDA History

DateValue
2025
-5.48(-42.5%)
DateValue
2024
-9.53

FAQ

  • What is Contineum Therapeutics Class A EV/EBITDA?
  • What is the all time high EV/EBITDA for Contineum Therapeutics Class A?
  • What is CTNM EV/EBITDA year-to-date change?

What is Contineum Therapeutics Class A EV/EBITDA?

The current EV/EBITDA of CTNM is -5.48

What is the all time high EV/EBITDA for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high EV/EBITDA is 27.66

What is CTNM EV/EBITDA year-to-date change?

Contineum Therapeutics Class A EV/EBITDA has changed by +4.05 (+42.50%) since the beginning of the year